Physician profile
Lawrence J Cisek
NPI 1659455616
$9,045.57
in general payments reported to CMS, 2019-2025
14 companies · $54.01 in 2025
The $54.01 reported for 2025 was less than what a typical Pediatric Urology provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $303 · 2021: $3,811 · 2022: $3,614 · 2023: $348 · 2024: $227 · 2025: $54.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Richard Wolf Medical Instruments Corp. | $7,051.78 | 2019-2022 | |
| Cook Medical LLC | $328.36 | 2019-2025 | Litho 150 |
| Medtronic, INC. | $319.30 | 2021-2023 | Interstim |
| Ethicon US, LLC | $225.38 | 2020-2024 | Echelon Flex |
| Teleflex LLC | $179.86 | 2023 | Urolift |
| Ambu INC. | $157.03 | 2021-2022 | |
| Novo Nordisk Health Care Ag | $124.00 | 2024 | |
| Baxter Healthcare | $119.09 | 2020 | |
| Genzyme Corporation | $116.87 | 2020 | |
| Axonics, INC. | $115.98 | 2022 | |
| Endo Pharmaceuticals INC. | $110.30 | 2021 | |
| Boston Scientific Corporation | $92.75 | 2022 | |
| Novo Nordisk INC | $58.66 | 2024-2025 | Rivfloza |
| Stryker Corporation | $46.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Cisek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.